Table 5.

AORs for the Prevalence of EBP/HTN and HTN Per 2-Year Survey Cycle, Among US Youths, 2003–2016 (N=12 249)

Model	EBP/HTN			HTN
	AOR (95% CI)	β-Coefficient	P Value	AOR (95% CI)	β-Coefficient	P Value
1*	0.92 (0.87–0.96)	−0.086	<0.001	0.89 (0.83–0.95)	−0.118	0.001
2†	0.91 (0.86–0.96)	−0.095	<0.001	0.88 (0.82–0.95)	−0.126	0.001
3‡	0.91 (0.87–0.96)	−0.089	0.001	0.89 (0.82–0.96)	−0.119	0.002
4§	0.91 (0.86–0.96)	−0.096	<0.001	0.88 (0.82–0.95)	−0.123	0.001
5∥	0.90 (0.85–0.95)	−0.103	<0.001	0.88 (0.81–0.95)	−0.130	0.001
6¶	0.91 (0.87–0.96)	−0.093	<0.001	0.88 (0.82–0.95)	−0.123	0.001
7#	0.91 (0.87–0.96)	−0.089	0.001	0.89 (0.82–0.96)	−0.118	0.002

AOR indicates adjusted odds ratio; EBP, elevated blood pressure or hypertension; and HTN, hypertension.

^*Model 1 is adjusted for survey cycle, age (y), sex, and race and Hispanic origin.

^†Model 2 is model 1 plus weight status

^‡Model 3 is model 2 plus usual daily sodium intake (mg).

^§Model 4 is model 3 plus usual daily energy intake (kcal).

^∥Model 5 is model 2 plus usual sodium density (mg/1000 kcal) and usual daily energy intake (kcal).

^¶Model 6 is model 2 plus usual sodium-to-potassium ratio (mmol/mmol).

^#Model 7 is model 6 plus usual daily potassium intake (mmol).